0001209191-23-018243.txt : 20230313
0001209191-23-018243.hdr.sgml : 20230313
20230313174752
ACCESSION NUMBER: 0001209191-23-018243
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230309
FILED AS OF DATE: 20230313
DATE AS OF CHANGE: 20230313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Giambastiani Edmund P Jr
CENTRAL INDEX KEY: 0001425411
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34410
FILM NUMBER: 23728424
MAIL ADDRESS:
STREET 1: C/O MONSTER WORLDWIDE, INC.
STREET 2: 622 THIRD AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: First Eagle Alternative Capital BDC, Inc.
CENTRAL INDEX KEY: 0001464963
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 BOYLSTON STREET
STREET 2: SUITE 1250
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: (800) 450-4424
MAIL ADDRESS:
STREET 1: 500 BOYLSTON STREET
STREET 2: SUITE 1250
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: THL Credit, Inc.
DATE OF NAME CHANGE: 20090527
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-09
1
0001464963
First Eagle Alternative Capital BDC, Inc.
FCRD
0001425411
Giambastiani Edmund P Jr
500 BOYLSTON STREET
SUITE 1250
BOSTON
MA
02116
1
0
0
0
Common Stock
2023-03-09
4
D
0
1924
D
0
D
On March 9, 2023, pursuant to an Agreement and Plan of Merger dated as of October 3, 2022 (the "Merger Agreement"), First Eagle Alternative Capital BDC, Inc., Crescent Capital BDC, Inc. ("CCAP"), Echelon Acquisition Sub, Inc., Echelon Acquisition Sub LLC and Crescent Cap Advisors, LLC ("CCAP Advisor") effected a merger pursuant to which CCAP acquired all of the outstanding shares of FCRDs common stock in a multi-step stock and cash transaction (the "Mergers"). Pursuant to the Merger Agreement, upon completion of the Mergers, each issued and outstanding share of FCRD common stock was converted into the right to receive a pro rata portion, subject to FCRD stockholder elections and the adjustment mechanisms set forth in the Merger Agreement with respect to the CCAP Consideration (as defined below), of (1) approximately $8.6 million in cash payable by CCAP, (2) 6,174,383 validly issued, fully paid and
continued from footnote 1: non-assessable shares of CCAPs common stock, par value $0.001 per share (together, the "CCAP Consideration") and (3) $35 million in cash payable by CCAP Advisor. The disposition reported in this Form 4 is an exempt transaction.
/s/ Sabrina Rusnak-Carlson as Attorney -in-Fact
2023-03-13